MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
microRNA-544 promoted human osteosarcoma cell proliferation by downregulating AXIN2 expression	https://doi.org/10.3892/ol.2018.8218	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Potential Role of Long Non-Coding RNA ANRIL in Pediatric Medulloblastoma Through Promotion on Proliferation and Migration by Targeting miR-323.	https://doi.org/10.1002/jcb.26141	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway.	https://doi.org/10.4103/0973-1482.77072	2010	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-21 suppression impedes medulloblastoma cell migration.	https://doi.org/10.1016/j.ejca.2011.06.041	2011	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3).	https://doi.org/10.1111/bpa.12014	2012	Cell line 6 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
"MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma"	https://doi.org/10.1159/000430308	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.	https://doi.org/10.1016/j.humpath.2009.02.003	2009	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-522-3p Promotes Osteosarcoma Cell Growth By Regulating Glucose Uptake And GLUT1 Expression	https://doi.org/10.2147/OTT.S217324	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2	https://doi.org/10.3892/ol.2018.9451	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation	https://doi.org/10.1016/j.cellsig.2009.07.019	2009	Cell line 0 Master/Detail View	Cell line and drug 9 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells	https://doi.org/10.1038/sj.onc.1210293	2007	Cell line 3 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells	https://doi.org/10.1073/pnas.0700071104	2007	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4?	https://doi.org/10.1080/21691401.2019.1637886	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
BMP-2 and miR-29c in osteosarcoma tissues on proliferation and invasion of osteosarcoma cells	https://doi.org/10.3892/ol.2019.10229	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-125b is a novel negative regulator of p53	https://doi.org/10.1101/gad.1767609	2009	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis	https://doi.org/10.1080/21691401.2019.1648285	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/?-catenin signaling pathway by enhancing AXIN1	https://doi.org/10.1016/j.yexmp.2019.03.001	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2	https://doi.org/10.3892/or.2018.6601	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
High impact of miRNA-4521 on FOXM1 expression in medulloblastoma.	https://doi.org/10.1038/s41419-019-1926-1	2019	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma.	https://doi.org/10.1038/bjc.2013.764	2013	Cell line 2 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications